Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.2 USD | +0.50% | +0.19% | -3.54% |
29/04 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
26/04 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.54% | 184B | |
-0.58% | 109B | |
-2.74% | 68.37B | |
+4.84% | 51.56B | |
+10.40% | 44.69B | |
+3.32% | 41.49B | |
+2.87% | 26.75B | |
+4.61% | 26.7B | |
+12.53% | 25.68B | |
-0.22% | 24.8B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- BTIG Adjusts Abbott Laboratories' Price Target to $138 From $143, Reiterates Buy Rating